Maryland Oncology Hematology remains open while making accommodations for the health and safety of our patients. If you believe you have been exposed to COVID-19 or have symptoms of COVID-19 including fever, cough, sore throat or shortness of breath, please call our office before you arrive. Any patient that has traveled out of state, please call before your appointment for travel information and review our travel policy. Our Mt. Airy location is now open and Wheaton patients now call Rockville & Germantown. View more information.


Mohit Narang, M.D.

Mohit Narang, M.D.


Medical Oncology


10710 Charter Dr #G020 Columbia, MD 21044
Phone: 410-964-2212
Fax: 410-964-0380
View Map



Mohit Narang, M.D.


Dayanand Medical College, Ludhiana, India


Internal Medicine, Christ Hospital in Cincinnati, Ohio


Hematology & Oncology, Michigan State University, Lansing, MI

Board Certification

  • Medical Oncology
  • Internal Medicine


As an active participant in the medical community, Dr. Narang has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology.

Dr. Narang resides in Clarksville, Maryland with his wife and two children. He enjoys camping, trekking and playing squash in his spare time.

Dr. Narang discusses how to reduce the risk of colon cancer:


Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study
H Yimer, J Melear, E Faber, WI Bensinger, JM Burke, M Narang, ...
British journal of haematology 185 (3), 492-502

Heterogeneity of second-line treatment for patients with multiple myeloma in the Connect MM Registry (2010-2016)
S Jagannath, R Abonour, BGM Durie, C Gasparetto, JW Hardin, ...
Clinical Lymphoma Myeloma and Leukemia 18 (7), 480-485. e3

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
S Jagannath, R Abonour, BGM Durie, M Narang, HR Terebelo, ...
Blood advances 2 (13), 1608-1615

More Publications